Sumatriptan as a treatment for cyclic vomiting syndrome: A clinical trial
Background and objective: Cyclic vomiting syndrome (CVS) is associated with migraine. This study aimed to evaluate the efficacy of sumatriptan in treating CVS. Methods: Twelve patients were enrolled in this trial. Sumatriptan was administered either subcutaneously [(age × 4 + 20)/100 × 3 mg] or by n...
Gespeichert in:
| Veröffentlicht in: | Cephalalgia 2011-03, Vol.31 (4), p.504-507 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 507 |
|---|---|
| container_issue | 4 |
| container_start_page | 504 |
| container_title | Cephalalgia |
| container_volume | 31 |
| creator | Hikita, Toshiyuki Kodama, Hiroko Kaneko, Sono Amakata, Kaori Ogita, Kaori Mochizuki, Daishi Kaga, Fumiaya Nakamoto, Natsue Fujii, Yasushi Kikuchi, Akira |
| description | Background and objective: Cyclic vomiting syndrome (CVS) is associated with migraine. This study aimed to evaluate the efficacy of sumatriptan in treating CVS.
Methods: Twelve patients were enrolled in this trial. Sumatriptan was administered either subcutaneously [(age × 4 + 20)/100 × 3 mg] or by nasal spray (NS; 20 mg). Response to the treatment was classified as complete, effective, or noneffective.
Results: Eleven patients, who presented with 35 attacks, were treated by subcutaneous injection of sumatriptan. The treatment was responsive in 19 attacks. The efficacy of sumatriptan was high in attacks that occurred in cases with a family history of migraine compared to those without (p = .0482). Five patients were treated with sumatriptan NS for six attacks. The treatment was completely responsive in two of six attacks. We observed no adverse effects associated with sumatriptan treatment in this trial.
Conclusion: We conclude that sumatriptan has potential efficacy in treating of patients with CVS. |
| doi_str_mv | 10.1177/0333102410390398 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_AFRWT</sourceid><recordid>TN_cdi_proquest_miscellaneous_904468939</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_0333102410390398</sage_id><sourcerecordid>904468939</sourcerecordid><originalsourceid>FETCH-LOGICAL-c368t-98bda5b1c6dfb147db398bee3fa92b4eeda6b83f506505642be99773530c5d623</originalsourceid><addsrcrecordid>eNqFkMtLAzEYxIMotlbvniQ3T6t5bLKJtyI-CgUP6jkk2WxJ2UdNskL_e1NaPQgifPAd5jfDMABcYnSDcVXdIkopRqTEiMp84ghMcclFQaQgx2C6k4udPgFnMa4RQowjfgomBOOyErScgsXr2OkU_CbpHuoINUzB6dS5PsFmCNBubest_Bw6n3y_gnHb12Ho3B2cw6z03uo2W7xuz8FJo9voLg5_Bt4fH97un4vly9Pifr4sLOUiFVKYWjODLa8bk1vUJvc2ztFGS2JK52rNjaANQ5zluiUxTsqqoowiy2pO6Axc73M3YfgYXUyq89G6ttW9G8aoJCrzBJLKf0nBGEGVQCyTaE_aMMQYXKM2wXc6bBVGare0-r10tlwdwkfTufrH8D1tBoo9EPXKqfUwhj7P8nfgF2nmhOI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>855207805</pqid></control><display><type>article</type><title>Sumatriptan as a treatment for cyclic vomiting syndrome: A clinical trial</title><source>Sage Journals GOLD Open Access 2024</source><creator>Hikita, Toshiyuki ; Kodama, Hiroko ; Kaneko, Sono ; Amakata, Kaori ; Ogita, Kaori ; Mochizuki, Daishi ; Kaga, Fumiaya ; Nakamoto, Natsue ; Fujii, Yasushi ; Kikuchi, Akira</creator><creatorcontrib>Hikita, Toshiyuki ; Kodama, Hiroko ; Kaneko, Sono ; Amakata, Kaori ; Ogita, Kaori ; Mochizuki, Daishi ; Kaga, Fumiaya ; Nakamoto, Natsue ; Fujii, Yasushi ; Kikuchi, Akira</creatorcontrib><description>Background and objective: Cyclic vomiting syndrome (CVS) is associated with migraine. This study aimed to evaluate the efficacy of sumatriptan in treating CVS.
Methods: Twelve patients were enrolled in this trial. Sumatriptan was administered either subcutaneously [(age × 4 + 20)/100 × 3 mg] or by nasal spray (NS; 20 mg). Response to the treatment was classified as complete, effective, or noneffective.
Results: Eleven patients, who presented with 35 attacks, were treated by subcutaneous injection of sumatriptan. The treatment was responsive in 19 attacks. The efficacy of sumatriptan was high in attacks that occurred in cases with a family history of migraine compared to those without (p = .0482). Five patients were treated with sumatriptan NS for six attacks. The treatment was completely responsive in two of six attacks. We observed no adverse effects associated with sumatriptan treatment in this trial.
Conclusion: We conclude that sumatriptan has potential efficacy in treating of patients with CVS.</description><identifier>ISSN: 0333-1024</identifier><identifier>EISSN: 1468-2982</identifier><identifier>DOI: 10.1177/0333102410390398</identifier><identifier>PMID: 21147834</identifier><language>eng</language><publisher>UK: SAGE Publications</publisher><subject>Adolescent ; Child ; Child, Preschool ; Female ; Humans ; Male ; Sumatriptan - therapeutic use ; Treatment Outcome ; Vomiting - diagnosis ; Vomiting - drug therapy ; Vomiting - physiopathology ; Young Adult</subject><ispartof>Cephalalgia, 2011-03, Vol.31 (4), p.504-507</ispartof><rights>International Headache Society 2011 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c368t-98bda5b1c6dfb147db398bee3fa92b4eeda6b83f506505642be99773530c5d623</citedby><cites>FETCH-LOGICAL-c368t-98bda5b1c6dfb147db398bee3fa92b4eeda6b83f506505642be99773530c5d623</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/0333102410390398$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/0333102410390398$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,776,780,21945,27830,27901,27902,44921,45309</link.rule.ids><linktorsrc>$$Uhttps://journals.sagepub.com/doi/full/10.1177/0333102410390398?utm_source=summon&utm_medium=discovery-provider$$EView_record_in_SAGE_Publications$$FView_record_in_$$GSAGE_Publications</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21147834$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hikita, Toshiyuki</creatorcontrib><creatorcontrib>Kodama, Hiroko</creatorcontrib><creatorcontrib>Kaneko, Sono</creatorcontrib><creatorcontrib>Amakata, Kaori</creatorcontrib><creatorcontrib>Ogita, Kaori</creatorcontrib><creatorcontrib>Mochizuki, Daishi</creatorcontrib><creatorcontrib>Kaga, Fumiaya</creatorcontrib><creatorcontrib>Nakamoto, Natsue</creatorcontrib><creatorcontrib>Fujii, Yasushi</creatorcontrib><creatorcontrib>Kikuchi, Akira</creatorcontrib><title>Sumatriptan as a treatment for cyclic vomiting syndrome: A clinical trial</title><title>Cephalalgia</title><addtitle>Cephalalgia</addtitle><description>Background and objective: Cyclic vomiting syndrome (CVS) is associated with migraine. This study aimed to evaluate the efficacy of sumatriptan in treating CVS.
Methods: Twelve patients were enrolled in this trial. Sumatriptan was administered either subcutaneously [(age × 4 + 20)/100 × 3 mg] or by nasal spray (NS; 20 mg). Response to the treatment was classified as complete, effective, or noneffective.
Results: Eleven patients, who presented with 35 attacks, were treated by subcutaneous injection of sumatriptan. The treatment was responsive in 19 attacks. The efficacy of sumatriptan was high in attacks that occurred in cases with a family history of migraine compared to those without (p = .0482). Five patients were treated with sumatriptan NS for six attacks. The treatment was completely responsive in two of six attacks. We observed no adverse effects associated with sumatriptan treatment in this trial.
Conclusion: We conclude that sumatriptan has potential efficacy in treating of patients with CVS.</description><subject>Adolescent</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Sumatriptan - therapeutic use</subject><subject>Treatment Outcome</subject><subject>Vomiting - diagnosis</subject><subject>Vomiting - drug therapy</subject><subject>Vomiting - physiopathology</subject><subject>Young Adult</subject><issn>0333-1024</issn><issn>1468-2982</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMtLAzEYxIMotlbvniQ3T6t5bLKJtyI-CgUP6jkk2WxJ2UdNskL_e1NaPQgifPAd5jfDMABcYnSDcVXdIkopRqTEiMp84ghMcclFQaQgx2C6k4udPgFnMa4RQowjfgomBOOyErScgsXr2OkU_CbpHuoINUzB6dS5PsFmCNBubest_Bw6n3y_gnHb12Ho3B2cw6z03uo2W7xuz8FJo9voLg5_Bt4fH97un4vly9Pifr4sLOUiFVKYWjODLa8bk1vUJvc2ztFGS2JK52rNjaANQ5zluiUxTsqqoowiy2pO6Axc73M3YfgYXUyq89G6ttW9G8aoJCrzBJLKf0nBGEGVQCyTaE_aMMQYXKM2wXc6bBVGare0-r10tlwdwkfTufrH8D1tBoo9EPXKqfUwhj7P8nfgF2nmhOI</recordid><startdate>20110301</startdate><enddate>20110301</enddate><creator>Hikita, Toshiyuki</creator><creator>Kodama, Hiroko</creator><creator>Kaneko, Sono</creator><creator>Amakata, Kaori</creator><creator>Ogita, Kaori</creator><creator>Mochizuki, Daishi</creator><creator>Kaga, Fumiaya</creator><creator>Nakamoto, Natsue</creator><creator>Fujii, Yasushi</creator><creator>Kikuchi, Akira</creator><general>SAGE Publications</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope></search><sort><creationdate>20110301</creationdate><title>Sumatriptan as a treatment for cyclic vomiting syndrome: A clinical trial</title><author>Hikita, Toshiyuki ; Kodama, Hiroko ; Kaneko, Sono ; Amakata, Kaori ; Ogita, Kaori ; Mochizuki, Daishi ; Kaga, Fumiaya ; Nakamoto, Natsue ; Fujii, Yasushi ; Kikuchi, Akira</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c368t-98bda5b1c6dfb147db398bee3fa92b4eeda6b83f506505642be99773530c5d623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adolescent</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Sumatriptan - therapeutic use</topic><topic>Treatment Outcome</topic><topic>Vomiting - diagnosis</topic><topic>Vomiting - drug therapy</topic><topic>Vomiting - physiopathology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hikita, Toshiyuki</creatorcontrib><creatorcontrib>Kodama, Hiroko</creatorcontrib><creatorcontrib>Kaneko, Sono</creatorcontrib><creatorcontrib>Amakata, Kaori</creatorcontrib><creatorcontrib>Ogita, Kaori</creatorcontrib><creatorcontrib>Mochizuki, Daishi</creatorcontrib><creatorcontrib>Kaga, Fumiaya</creatorcontrib><creatorcontrib>Nakamoto, Natsue</creatorcontrib><creatorcontrib>Fujii, Yasushi</creatorcontrib><creatorcontrib>Kikuchi, Akira</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><jtitle>Cephalalgia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Hikita, Toshiyuki</au><au>Kodama, Hiroko</au><au>Kaneko, Sono</au><au>Amakata, Kaori</au><au>Ogita, Kaori</au><au>Mochizuki, Daishi</au><au>Kaga, Fumiaya</au><au>Nakamoto, Natsue</au><au>Fujii, Yasushi</au><au>Kikuchi, Akira</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sumatriptan as a treatment for cyclic vomiting syndrome: A clinical trial</atitle><jtitle>Cephalalgia</jtitle><addtitle>Cephalalgia</addtitle><date>2011-03-01</date><risdate>2011</risdate><volume>31</volume><issue>4</issue><spage>504</spage><epage>507</epage><pages>504-507</pages><issn>0333-1024</issn><eissn>1468-2982</eissn><abstract>Background and objective: Cyclic vomiting syndrome (CVS) is associated with migraine. This study aimed to evaluate the efficacy of sumatriptan in treating CVS.
Methods: Twelve patients were enrolled in this trial. Sumatriptan was administered either subcutaneously [(age × 4 + 20)/100 × 3 mg] or by nasal spray (NS; 20 mg). Response to the treatment was classified as complete, effective, or noneffective.
Results: Eleven patients, who presented with 35 attacks, were treated by subcutaneous injection of sumatriptan. The treatment was responsive in 19 attacks. The efficacy of sumatriptan was high in attacks that occurred in cases with a family history of migraine compared to those without (p = .0482). Five patients were treated with sumatriptan NS for six attacks. The treatment was completely responsive in two of six attacks. We observed no adverse effects associated with sumatriptan treatment in this trial.
Conclusion: We conclude that sumatriptan has potential efficacy in treating of patients with CVS.</abstract><cop>UK</cop><pub>SAGE Publications</pub><pmid>21147834</pmid><doi>10.1177/0333102410390398</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | ISSN: 0333-1024 |
| ispartof | Cephalalgia, 2011-03, Vol.31 (4), p.504-507 |
| issn | 0333-1024 1468-2982 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_904468939 |
| source | Sage Journals GOLD Open Access 2024 |
| subjects | Adolescent Child Child, Preschool Female Humans Male Sumatriptan - therapeutic use Treatment Outcome Vomiting - diagnosis Vomiting - drug therapy Vomiting - physiopathology Young Adult |
| title | Sumatriptan as a treatment for cyclic vomiting syndrome: A clinical trial |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T07%3A21%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_AFRWT&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sumatriptan%20as%20a%20treatment%20for%20cyclic%20vomiting%20syndrome:%20A%20clinical%20trial&rft.jtitle=Cephalalgia&rft.au=Hikita,%20Toshiyuki&rft.date=2011-03-01&rft.volume=31&rft.issue=4&rft.spage=504&rft.epage=507&rft.pages=504-507&rft.issn=0333-1024&rft.eissn=1468-2982&rft_id=info:doi/10.1177/0333102410390398&rft_dat=%3Cproquest_AFRWT%3E904468939%3C/proquest_AFRWT%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=855207805&rft_id=info:pmid/21147834&rft_sage_id=10.1177_0333102410390398&rfr_iscdi=true |